Skip to main content
Log in

Salmefamol orally in asthmatics—Two doses compared

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The responses of twelve patients with chronic asthma to salmefamol 1 mg and 2 mg, taken orally, were compared in a double-blind cross-over study. Both produced a rise of 40 – 50 % in PEFR and FEV1. Statistically significant improvements were maintained for three to four hours, and 20 % improvements for four to six hours. There was no significantly different effect on ventilatory capacity between the two doses. After the 2 mg dose there was a statistically significant fall in diastolic blood pressure at 1 and 1 1/2 hours. Four patients experienced tremor and this was the only side-effect noted. The possible reasons for failure to demonstrate a greater effect with the higher dose are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bartley, D., Jack, D., Lunts, L.H.C., Ritchie, A.C.: New class of selective stimulants of β — adrenergic receptors. Nature (Lond.)219, 861–862 (1968)

    Google Scholar 

  2. Shenfield, G.M., Paterson, J.W.: Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax28, 124–128 (1973)

    Google Scholar 

  3. Sillett, R.W., Dash, C.H., McNicol, M.W.: Comparison of salmefamol with salbutamol aerosols in asthmatics. Europ. J. clin. Pharmacol. (in press) (1975)

  4. Kennedy, M.C.S., Dash, C.H.: The bronchodilator effect of a new adrenergic aerosol — salmefamol. Acta allerg. (Kbh.)27, 22–26 (1972)

    Google Scholar 

  5. Cotes, J.E.: Lung function at different stages in life, including normal values. In: Lung function (2nd Ed.), pp. 345–391. Oxford and Edinburgh: Blackwell Scientific Publications 1968

    Google Scholar 

  6. Evans, M.E., Shenfield, G.M., Paterson, J.W.: The clinical pharmacology of salmefamol. Brit. J. clin. Pharmacol,1, 391–397 (1974)

    Google Scholar 

  7. Watson, J.M., Richens, A.: The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate. Brit. J. clin. Pharmacol.1, 223–227 (1974)

    Google Scholar 

  8. Cochrane, G.M., Clark, T.J.H., Hanan, M.E.: The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline. Curr. med. Res. & Opin.1, 517–523 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sillett, R.W., Dash, C.H. & McNicol, M.W. Salmefamol orally in asthmatics—Two doses compared. Eur J Clin Pharmacol 9, 281–284 (1976). https://doi.org/10.1007/BF00561661

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561661

Key words

Navigation